FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

A correction has been published: N Engl J Med 2006;354(4):417.

Previous Volume 353:1252-1260 September 22, 2005 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article Related Article by Itskowitz, M. S. PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.

A 41-year-old man with dyslipidemia, hypertension, and a history of myocardial infarction four years previously comes to establish care. He is physically inactive and consumes a diet high in saturated fat. He does not smoke. Medications include a statin, a beta-blocker, an angiotensin-converting – enzyme inhibitor, and aspirin. His blood pressure is 110/80 mm Hg, and his body-mass index (the weight in . . . [Full Text of this Article]

The Clinical Problem

Strategies and Evidence

Lifestyle Modifications

            Exercise

            Smoking Cessation

            Weight Control

            Alcohol Intake

            Dietary Fat Intake

            Lifestyle and Modifying Factors

Medication

            Niacin

            Fibrates

            Statins

            Combination Therapy

Areas of Uncertainty

Guidelines from Professional Associations

Summary and Recommendations

Source Information

From the Johns Hopkins Hospital, Baltimore.

Address reprint requests to Dr. Blumenthal at Johns Hopkins Hospital, Blalock 524C, Johns Hopkins Ciccarone Preventive Cardiology Center, 600 N. Wolfe St., Baltimore, MD 21287, or at rblument@jhmi.edu

This article has been cited by other articles:

• Davidson, M., Meyer, P. M., Haffner, S., Feinstein, S., D'Agostino, R. Sr, Kondos, G. T., Perez, A., Chen, Z., Mazzone, T. (2008). Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus. Circulation 117: 2123-2130 [Abstract] [Full Text]  
• Sarov-Blat, L., Kiss, R. S., Haidar, B., Kavaslar, N., Jaye, M., Bertiaux, M., Steplewski, K., Hurle, M. R., Sprecher, D., McPherson, R., Marcel, Y. L. (2007). Predominance of a Proinflammatory Phenotype in Monocyte-Derived Macrophages From Subjects With Low Plasma HDL-Cholesterol. Arterioscler. Thromb. Vasc. Bio. 27: 1115-1122 [Abstract] [Full Text]  
• Sola, R., Godas, G., Ribalta, J., Vallve, J.-C., Girona, J., Anguera, A., Ostos, M., Recalde, D., Salazar, J., Caslake, M., Martin-Lujan, F., Salas-Salvado, J., Masana, L. (2007). Effects of soluble fiber (Plantago ovata husk) on plasma lipids, lipoproteins, and apolipoproteins in men with ischemic heart disease. Am. J. Clin. Nutr. 85: 1157-1163 [Abstract] [Full Text]  
• Eichinger, S., Pecheniuk, N. M., Hron, G., Deguchi, H., Schemper, M., Kyrle, P. A., Griffin, J. H. (2007). High-Density Lipoprotein and the Risk of Recurrent Venous Thromboembolism. Circulation 115: 1609-1614 [Abstract] [Full Text]  
• Grant, R. W., Meigs, J. B. (2007). Prevalence and Treatment of Low HDL Cholesterol Among Primary Care Patients With Type 2 Diabetes: An unmet challenge for cardiovascular risk reduction. Diabetes Care 30: 479-484 [Abstract] [Full Text]  
• Sanossian, N., Saver, J. L., Navab, M., Ovbiagele, B. (2007). High-Density Lipoprotein Cholesterol: An Emerging Target for Stroke Treatment. Stroke 38: 1104-1109 [Abstract] [Full Text]  
• Greenstone, L. (2007). Rationale for Intervention to Reduce Risk of Coronary Heart Disease: A General Internist's Perspective. AMERICAN JOURNAL OF LIFESTYLE MEDICINE 1: 20-23 [Abstract]  
• Mazzali, G., Di Francesco, V., Zoico, E., Fantin, F., Zamboni, G., Benati, C., Bambara, V., Negri, M., Bosello, O., Zamboni, M. (2006). Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women.. Am. J. Clin. Nutr. 84: 1193-1199 [Abstract] [Full Text]  
• Paramsothy, P., Knopp, R. (2006). Management of dyslipidaemias.. Heart 92: 1529-1534 [Full Text]  
• Kontush, A., Chapman, M. J. (2006). Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis. Pharmacol. Rev. 58: 342-374 [Abstract] [Full Text]  
• Itskowitz, M. S., Pollock, J. L., Katan, M. B., Xie, Y., Davidson, N. O., Ashen, D., Blumenthal, R. S. (2006). Low HDL cholesterol levels.. NEJM 354: 417-419 [Full Text]